Carboplatin plus nab-Paclitaxel versus docetaxel for elderly squamous non-small cell lung cancer (CAPITAL study)
Phase of Trial: Phase III
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Docetaxel
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- Acronyms CAPITAL
- 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress.
- 02 Dec 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan record.
- 27 Nov 2015 New trial record